Childrens Sabadil

Manufacturer: Laboratoires Boiron | Boiron Inc. | Boiron
Effective date: 2020-11-02
Label type: HUMAN OTC DRUG LABEL
Version: 8
Source: full-release
Hydrated at: 2026-06-01 02:13:27

Label at a glance#

ProductChildrens Sabadil

Active ingredientONION, AMBROSIA ARTEMISIIFOLIA, HISTAMINE DIHYDROCHLORIDE, SCHOENOCAULON OFFICINALE SEED, EUPHRASIA STRICTA, SOLIDAGO VIRGAUREA FLOWERING TOP

Label structure10 sections

Indications and uses

temporarily relieves on or more of these symptoms of hay fever or other uppper respiratory allergies: itchy and watery eyes sneezing runny nose itchy throat and nose

Dosage and administration

Children 2 years of age and older: At the onser of symptoms, dissolve 5 pellets under the tounge every 15 minutes for 1 hour. Then, dissolve 5 pellets under the tounge 3 times a day until symptoms are releived. Children under 2 years of age: Ask a doctor.

Contacts and useful links#

PhoneLabel contact1-800-264-7661

Label contents#

Full prescribing information#

Active Ingredients**

OTC - ACTIVE INGREDIENT SECTION

Allium cepa 5C HPUS
Ambrosia artemisiaefolia 5C HPUS
Euphrasia officinalis 5C HPUS
Histaminum hydrochloricum 9C HPUS
Sabadilla 5C HPUS
Solidago virgaurea 5C HPUS

The letters HPUS indicate that this ingredient is officially included in the Homeopathic Pharmacopoeia of the United States.

Purpose*

OTC - PURPOSE SECTION

Allium cepa 5C HPUS ..... Relieves runny nouse associated with allergies
Ambrosia artemisiaefolia 5C HPUS ..... Relieves spasmodic cough associated with hay fever
Histaminum hydrochloricum 9C HPUS ..... Relieves symptoms of allergic conditions
Euphrasia officinalis 5C HPUS ..... Relieves burning, irritated eyes
Sabadilla 5C HPUS ..... Relieves sneezing associated with allergies
Solidago virgaurea 5C HPUS ..... Relieves abundant nasal discharge

Uses*

INDICATIONS & USAGE SECTION

temporarily relieves on or more of these symptoms of hay fever or other uppper respiratory allergies:
itchy and watery eyes
sneezing
runny nose
itchy throat and nose

Warnings

WARNINGS SECTION

OTC - ASK DOCTOR SECTION

Ask a doctor before use in children under 2 years of age.

Stop use and ask a doctor if

OTC - STOP USE SECTION

symptoms persist for more than 7 days or worsen.

OTC - PREGNANCY OR BREAST FEEDING SECTION

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Directions

DOSAGE & ADMINISTRATION SECTION

Other information

SPL UNCLASSIFIED SECTION

do not use if the label sealing the clear tube cap is broken or missing

Inactive ingredients

INACTIVE INGREDIENT SECTION

lactose, sucrose

Questions, Comments?

OTC - QUESTIONS SECTION

BoironUSA.com
info@boiron.com
1-800-BOIRON-1 (1-800-264-7661)
Distributed by Boiron Inc., 6 Campus Boulevard, Newtown Square, PA 19073-3267

Notes:

SPL UNCLASSIFIED SECTION

*These "Uses" have not been evaluated by the Food And Drug Administration.
**C, K, CK and X are homeopathic dilutions: see BoironUSA.com/info for details.

Principle Display Panel - Childrens Sabadil

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Principle Display Panel - Childrens Sabadil

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
0220-9061-42	2023-01-30	C162847	48780-1	9d75b9d1-12cf-f424-e053-dadaa90a57ce	Childrens Sabadil
0220-9061-42	2020-02-26	C162847	48780-1	9d75b9d1-12cf-f424-e053-dadaa90a57ce	Childrens Sabadil
0220-9061-42	2020-01-31	C162847	48780-1	9d75b9d1-12cf-f424-e053-dadaa90a57ce	Childrens Sabadil

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
0220-9061-41	Childrens Sabadil	80 in 1 TUBE	PELLET	80		8
0220-9061-42	Childrens Sabadil	2 in 1 PACKAGE	PELLET	2		8

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0220-9061	CHILDRENS SABADIL (ONION, AMBROSIA ARTEMISIIFOLIA, HISTAMINE DIHYDROCHLORIDE, SCHOENOCAULON OFFICINALE SEED, EUPHRASIA STRICTA, SOLIDAGO VIRGAUREA FLOWERING TOP) PELLET [LABORATOIRES BOIRON]	8	Legacy NDC, 2 package rows	20201104_edc1bcd5-fcad-40fa-94b0-12518434b105.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
AMBROSIA ARTEMISIIFOLIA	ACTIVE INGREDIENT	9W34L2CQ9A	4
EUPHRASIA STRICTA	ACTIVE INGREDIENT	C9642I91WL	4
HISTAMINE DIHYDROCHLORIDE	ACTIVE INGREDIENT	3POA0Q644U	4
ONION	ACTIVE INGREDIENT	492225Q21H	4
SCHOENOCAULON OFFICINALE SEED	ACTIVE INGREDIENT	6NAF1689IO	4
SOLIDAGO VIRGAUREA FLOWERING TOP	ACTIVE INGREDIENT	5405K23S50	4
AMBROSIA ARTEMISIIFOLIA	ACTIVE MOIETY	9W34L2CQ9A	4
EUPHRASIA STRICTA	ACTIVE MOIETY	C9642I91WL	4
HISTAMINE	ACTIVE MOIETY	820484N8I3	4
ONION	ACTIVE MOIETY	492225Q21H	4
SCHOENOCAULON OFFICINALE SEED	ACTIVE MOIETY	6NAF1689IO	4
SOLIDAGO VIRGAUREA FLOWERING TOP	ACTIVE MOIETY	5405K23S50	4
LACTOSE	INACTIVE INGREDIENT	J2B2A4N98G	4
SUCROSE	INACTIVE INGREDIENT	C151H8M554	4

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 11 matching rows.

Childrens Sabadil
ONION, AMBROSIA ARTEMISIIFOLIA, HISTAMINE DIHYDROCHLORIDE, SCHOENOCAULON OFFICINALE SEED, EUPHRASIA STRICTA, SOLIDAGO VIRGAUREA FLOWERING TOP
SUCROSE
LACTOSE
ONION
AMBROSIA ARTEMISIIFOLIA
HISTAMINE DIHYDROCHLORIDE
HISTAMINE
SCHOENOCAULON OFFICINALE SEED
EUPHRASIA STRICTA
SOLIDAGO VIRGAUREA FLOWERING TOP

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
0220-9061	0220-9061-41, 0220-9061-42

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 8 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
SUCROSE	C151H8M554	IACT
LACTOSE	J2B2A4N98G	IACT
ONION	492225Q21H	ACTIB
AMBROSIA ARTEMISIIFOLIA	9W34L2CQ9A	ACTIB
HISTAMINE DIHYDROCHLORIDE	3POA0Q644U	ACTIB
SCHOENOCAULON OFFICINALE SEED	6NAF1689IO	ACTIB
EUPHRASIA STRICTA	C9642I91WL	ACTIB
SOLIDAGO VIRGAUREA FLOWERING TOP	5405K23S50	ACTIB

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 2 · 84 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
SUCROSE	SUCROSE	C151H8M554	POWDER, FOR SOLUTION / ORAL		38666 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION / ORAL		48209 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	GRANULE, FOR SUSPENSION / ORAL	512.5 mg/5ml		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SOLUTION / ORAL		70000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, DELAYED RELEASE / ORAL	295.33 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, CHEWABLE / ORAL		1412 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, EMULSION / INTRAVENOUS		970 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, DELAYED RELEASE / ORAL		160 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, FILM COATED / ORAL		145 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, EXTENDED RELEASE / ORAL		619 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION/ DROPS / ORAL		3750 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION / INTRAVENOUS	203.5 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, COATED / ORAL	332.05 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE / RESPIRATORY (INHALATION)	44.4 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET / BUCCAL	296.7 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	LOZENGE / TRANSMUCOSAL		1255 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS		1 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, FILM COATED / ORAL	590 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, EXTENDED RELEASE / ORAL	400 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER / ORAL		27768 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	PASTILLE / ORAL	426 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / SUBLINGUAL	109 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	SOLUTION / ORAL	1682 mg/15ml		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET / RECTAL	20 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / ORAL		4249 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS	133 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	LIQUID / ORAL		37500 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		620 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVITARY	193.8 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, SOLUTION / INTRAVENOUS	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SYRUP / ORAL		46400 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION, SOLUTION / INTRAVENOUS	0.45 %w/v		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUPPOSITORY / RECTAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, COATED PELLETS / ORAL	135.2 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, EFFERVESCENT / ORAL	96.5 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS	133 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, EXTENDED RELEASE / ORAL	284.54 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / BUCCAL	109 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS	9.4 %w/v		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, COATED PELLETS / ORAL	59.8 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	POWDER / RESPIRATORY (INHALATION)	90 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS	900 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	ELIXIR / ORAL		18000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL		18790 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS		308 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, SUGAR COATED / ORAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CONCENTRATE / ORAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	119.12 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR	133 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TROCHE / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	DROPS / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CONCENTRATE / ORAL		4800 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, EXTENDED RELEASE / ORAL	120 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER, FOR SUSPENSION / ORAL		40017 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	FILM, EXTENDED RELEASE / TRANSDERMAL	675 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	SOLUTION / RECTAL	8 %w/v		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION / SUBCUTANEOUS	47.75 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, COATED, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	LOZENGE / BUCCAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
b32410f8-af85-789d-e053-2a95a90a3def			edc1bcd5-fcad-40fa-94b0-12518434b105	2020-11-02	Warnings	Exact identifier spl id: b32410f8-af85-789d-e053-2a95a90a3def spl set id: edc1bcd5-fcad-40fa-94b0-12518434b105

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.